RA prevalence is rising globally, while mortality rates are declining. Continued investigation aimed at elucidating RA risk factors, the transition from pre-RA to RA, extra-articular involvement, and multimorbidity remains critical to optimize patient outcomes.
Klingemann et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: